20-12-2023 01:50 PM | Source: Sushil Finance
 Ltd.jpg)
Neutral Kilitch Drugs (India) Ltd for Target Rs. 393 - Sushil Finance
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
We have coverage on Kilitch Drugs (India) Ltd. with a BUY rating on stock. Since our report, the stock has posted a high of Rs.381 today.
With the recent run-up in the share price (27% return), we are now changing our rating on the stock to Neutral.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report &
Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read
disclaimer before referring below views. Click Here For Disclaimer
Latest News
Buy Apollo Pipes Ltd or Target Rs. 276 By Yes Secur...
Renowned Musician Avadhoot Gupte Acquires Rs. 7.7 Cr...
C/D Ratio Nudges Downwards as Credit Offtake Moderat...
US Elections 2024: Limited Impact Expected on Indian...
Buy Godawari Power & Ispat Ltd or Target Rs. 276 By...
Views on Effect of US Elections on Indian Markets by...
HCLFoundation and UP Government Sign MoU to enhance ...
Quote on Markets By Vikram Kasat, Head - Advisory, P...
Qlik Opens Registration for Qlik Connect 2025, Its A...
Dr Reddy's Laboratories Ltd. Q2FY25 Result First Cut...
